Concept

Treatment of PTSD using MDMA (Ecstasy)

In 2021 the FDA approved the use of 3,4-methylenedioxymethamphetamine (MDMA) for the treatment of PTSD. The compound was studied as a treatment as studies suggest it acts by binding to the presynaptic serotonin transporters inducing a release of serotonin. The trials conducted administered three doses of MDMA paired with manualized therapy during an eighteen-week treatment plan. The results of the study showed significantly reduced symptoms of depression as well as regulated amygdalar serotonergic function in comparison to the control (placebo) group. Each study conducted showed similar results which led to the approval for the regulated use of MDMA to treat PTSD symptoms.

0

1

Updated 2023-05-10

Tags

Behavioral Neuroscience

Psychology

Neuroscience (Neurobiology)

Social Science

Empirical Science

Science

Life Science / Biology

Biomedical Sciences

Natural Science

Related